Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

BACKGROUND AND AIMS: Hepatitis C virus (HCV) infection is associated with extrahepatic manifestations such as cryoglobulinemia and accounts for up to 90% of all cases of mixed cryoglobulinemia (MC). The present study aimed to evaluate the effect of sofosbuvir–daclatasvir therapy on symptomatic HCV-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Amro M, Osman, Heba A, Mahmoud, Hasan S, Hassan, Mohammed H, Hashim, Abdel-Kader A, Ameen, Hesham H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027820/
https://www.ncbi.nlm.nih.gov/pubmed/29983581
http://dx.doi.org/10.2147/IDR.S167093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027820/
https://www.ncbi.nlm.nih.gov/pubmed/29983581
http://dx.doi.org/10.2147/IDR.S167093

Ejemplares similares